ArticleCancers2023

Targeting Metabolic Vulnerabilities to Overcome Prostate Cancer Resistance: Dual Therapy with Apalutamide and Complex I Inhibition.

Valentin Baumgartner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.